Breaking News
Get 45% Off 0
🥇 Did you miss it? MPWR, our #1 AI-picked stock for 2025, is already up 17.71% so far.
See latest picks

Editor's Picks

Contribute
Geoff Considine, Ph.D
Despite Some Concerns, AbbVie Stock Is Still Worth A Look By Geoff Considine, Ph.D - Feb 16, 2022

ABBV faces a significant loss of revenue beginning in 2023 from Humira biosimilars For now, the company is turning in steady earnings growth Wall Street consensus outlook is bullish, but with only 3%...

Continue with Apple
Continue with Google
or
Sign up with Email